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Abstract
Background
The Hong Kong Government released a Reference Framework (RF-HT) for Hypertension
Care for Adults in Primary Care Settings since 2010. No studies have evaluated its adoption
by primary care physicians (PCPs) since its release.
Aim
We aimed to evaluate the level of PCPs’ adoption of the RF-HT and the potential barriers of
its use in family practice.
Design and setting
A cross-sectional study was conducted by a self-administered validated survey among all
PCPs in Hong Kong through various means.
Methods
We assessed the level of and factors associated with its adoption by multivariate logistic
regression modelling.
Result
A total of 3,857 invitation episodes were sent to 2,297 PCPs in 2014–2015. We received
383 completed questionnaires. The average score of adoption was 3.43 out of 4.00, and
47.5% of PCPs highly adopted RF-HT in their daily consultations. Male practitioners
(adjusted odds ratio [aOR] = 0.524, 95% CI = 0.290–0.948, p = 0.033) and PCPs of public
sector (aOR = 0.524, 95% CI = 0.292–0.940, p = 0.030) were significantly less likely to
adopt the RF-HT. PCPs with higher training completion or being academic fellow are more
likely to adopt RF-HT than those who were “nil to basic training completion” (aOR = 0.479,
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95% CI = 0.269–0.853, p = 0.012) or “higher trainee” (aOR = 0.302, 95% CI = 0.093–0.979,
p = 0.046). Three most-supported suggestions on RF-HT improvement were simplification
of RF-HT, provision of pocket version and promoting in patients.
Conclusion
Among PCP respondents, the adoption level of the RF-HT was high. These findings also
highlighted some factors associated with its adoption that could inform targeted interven-
tions for enhancing its use in clinical practice.
Introduction
Worldwide, hypertension accounts for 7.6 million premature deaths and 92 million disability-
adjusted life years (DALY) annually, and contributes to 47% of ischemic heart disease and 54%
of stroke [1]. Although its prevalence is growing [2, 3], its control rate remains low in many
countries [3–6]. In Hong Kong, the proportion of people diagnosed with hypertension
increased from 9.3% in 2008, to 10.3% in 2009/10, and 11.0% in 2011/12 [7]. However, accord-
ing to a recent territory-wide cohort study in Hong Kong [8], only 46% of respondents with
high blood pressure received diagnosis. The treatment rate and control rate were only 70%
and 42% among those diagnosed [8].
Primary Care Physicians (PCPs) play a crucial role to offer comprehensive, coordinated,
first-contact and continuing care for hypertensive patients in the community. However, sub-
optimal blood pressure control is often associated with poor adherence to hypertension frame-
works or guidelines among PCPs [9, 10]. Studies reported that non-adherence to the
guidelines would lead to wrong posture or positioning of patients while blood pressure was
taken[11, 12], omission of cardiovascular disease (CVD) risk estimation [9, 13–15], under or
over treatment [6, 14, 15], poor documentation [16] and lack of recommendations on lifestyle
modification provided to patients [6, 16, 17]. PCPs’ adherence to hypertension guidelines was
studied in many countries but not in Hong Kong.
Barriers of adherence to guidelines among PCPs included: (a) insufficient knowledge of the
guidelines [11, 18, 19] or the most updated evidence [6, 12–15, 20, 21]; (b) considered such
guidelines to be not clear, outdated, not applicable or not credible [6, 11, 15, 18, 19, 22, 23]; (c)
being junior PCPs [6, 11]; (f) lack of expectations on the impact of adopting guidelines [11, 18,
19, 21–26].
In 2010, the Primary Care Office of the Hong Kong Government produced the first refer-
ence framework for Hypertension Care (RF-HT) for Adults in Primary Care Settings and
updated in 2013 [27] (S1 File). The reference framework was the first standardized local hyper-
tension guidelines made for the whole healthcare system in Hong Kong, providing general ref-
erences for practice in primary care settings to support the policy of promoting primary care.
It displayed a different situation compared to other countries to develop realistic frameworks
suitable for local culture. Its implementation in primary care is expected to provide better
healthcare for hypertensive patients. However, the awareness and adoption level of this RF-HT
in local PCPs has not been evaluated.
The objective of this study is to investigate the awareness, adoption level, enabling factors
and barriers to the use of RF-HT among PCPs, as well as the factors associated with its adop-
tion. We aim to analyze these parameters in the context of the well-recognized “guideline
implementability framework” [28].
Hypertension reference framework in HK
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Method
Survey instrument
Based on literature review and focus group, the survey items were tailored-made to the local
context of primary healthcare by a panel consisted of family medicine specialists, public health
professionals and epidemiologists. A pilot-test was conducted in ten local PCPs, whereas the
questionnaire was finalized based on their feedback. The adoption level of the RF-HT was
assessed by PCPs’ reporting on their common practice for hypertension care, using a Likert
Scale of “1 = never”, “2 = sometimes”, “3 = often”, “4 = always” which produced a score of
RF-HT adoption.
Sampling frame and methodology
The targeted population of this study was all doctors working in primary care settings whose
clinical duties involved management of hypertensive patients. There were approximately 5,700
and 5,884 PCPs working in the private and public sector, between the year of 2014–2015 [29,
30]. The public sector included General Out-Patient Clinics (GOPCs) and Family Medicine
Specialist Clinics (FMSCs), Specialist Out-Patient Clinics (SOPCs) and staff clinics under the
jurisdiction of the Hospital Authority. Moreover, we also used a “central private practitioner
registry” which was established by us and reported in our previous work [31]. After omission
of duplication, it is consisted of comprehensive contact information of 2,297 registered private
doctors.
As the adoption rate of guidelines reported in the literatures [11, 12, 16, 17, 19, 24, 32]
ranges from 10–50%, we assumed 30% of PCPs would report that they “often” or “always” had
adopted the framework. The cut-off values were chosen arbitrary for there was no agreed
guideline on this. Targeting at a precision level of 0.05, a minimum of 323 subjects were
required based on the standard formula (i.e. precision = 1.96×
p
[(p(1-p)/N)], where p is the
proportion of PCPs who would highly adopt the reference framework). Given a response rate
of 11.4% from our previous PCP survey in the primary care sector with no incentives [31, 33],
we sent our survey invitations to all the public and private PCPs in the sampling frame in
order to achieve adequate sample size to assess the representativeness. And particularly in this
study, survey invitations were also sent by on-site visits and disseminated in Continuous Medi-
cal Education (CME) lunch seminars. According to our previous experience, a significantly
higher response rate could be achieved by reaching more potentially eligible PCPs not
included in the invitation list [31].
Hard copies of surveys were sent to the primary care clinics in the public sector via the
arrangements of the respective Chief of Service (COS), who participated in the coordination
of survey dissemination and collection. The surveys were all self-administered, and the com-
pleted surveys were returned via collection of the hard copies through postal means. For invi-
tations of the PCPs in the private sector, multiple channels were used including postage, e-
mail addresses and fax-lines, whichever was available. Original dissemination of e-survey was
conducted in early March 2016 and three separated reminders were sent in June 2016. For sur-
veys sent by postal means, postage-paid and self-return envelopes were provided to the partici-
pants. The PCPs were reminded not to complete a survey if they have already returned the
questionnaire. To enhance response rates, we sent up to three reminders to non-respondents
separated by three weeks after the date of survey invitation to the PCPs’ office. Upon comple-
tion of the questionnaire, they were given a HKD 50 supermarket coupon as an incentive. To
assure the confidentiality and anonymity, each doctor’s identity was replaced by a unique iden-
tifying number before data analysis.
Hypertension reference framework in HK
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Statistical analyses
The SPSS 21.0 (Chicago, Illinois) was used for data entry and analysis. The adoption level of
the hypertension reference framework was calculated as an overall score and presented in pro-
portions. In order to compare the difference between PCPs with high vs. low levels of adop-
tion, independent t-tests or Chi-square tests were performed for continuous or categorical
variables, respectively. The covariates significantly associated with adoption of RF-HT were
evaluated by multiple logistic regression analyses. P values <0.05 were regarded as statistically
significant.
Result
Characteristics of participants
A total of 3,857 surveys with the individual informed consent files were sent out through vari-
ous means including postage or fax-line or electronic web-based answering system (3,255),
invitation in the clusters of Hospital Authority (370), on-site visit (85) and recruitment in
CME luncheons in person (147). 383 surveys were returned by these means, giving a response
rate of 9.9%. The demographic characteristics of participating PCPs are shown in Table 1.
Difference in PCPs by adoption level of reference framework for
hypertension
The adoption level was analyzed with the assumption that the recommendations of reference
framework have been taken up in daily routine practice of doctor participants, whereas
“strongly disagree” and “disagree” were defined as low adoption while “agree” and “strongly
agree” were regarded as high adoption in each recommendation. Thus, the average score of
the adoption was computed as 3.43 (SD = 0.314), whereas the overall adoption was defined as
high when it obtained the score3.5 out of 4. Thus it was found that 47.5% of primary care
physicians strongly adopted this framework in their daily consultations. As shown in Table 2,
the recommendations from reference framework can be categorized in three parts, i.e. blood
pressure measurement, lifestyle modification and drug treatment. It is clear that all five recom-
mendations of lifestyle modification were highly adopted by the participants within range of
94.0–95.8%. However, >50% of doctors had no agreement on BP measurement for adult indi-
viduals every two years. Meanwhile, only 53.3% of practitioners preferred to set target BP
<130/80 mmHg. In the drug treatment part, all reached high consensus except “annual screen-
ing urine for protein/albumin in HT patients”. Moreover in Table 3, some characteristics of par-
ticipants were found as potential associated factors of RF-HT adoption.
In addition, Fig 1 showed the treatment algorithm for hypertensive patients which was rec-
ommended in the reference framework. The majority of participants highly agreed with the
treatment algorithm (Fig 2). Moreover, 371 out of 383 physicians highly adopted the reference
framework to initiate drug treatment when patient’s blood pressure is greater than 160 mmHg
after undergoing lifestyle modification (S1 Table). However, a total of 64.7% of the participants
showed disagreement to initiate the drug treatment with thiazide-type diuretic as the first line
drug treatment; instead, angiotensin-converting-enzyme inhibitor (ACEI) or calcium channel
blocker (CCB) was mostly considered by health professionals (data not shown).
Factors related to the adoption of reference framework
Potential factors associated with reference framework adoption were divided to four themes,
including guideline-related, patient-related, PCP-related and external factors. S2
Table presented potential factors affecting adoption at different levels. Multivariate logistic
Hypertension reference framework in HK
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regression was used to evaluate factors significantly associated with the adoption level of
the framework (shown in Table 4). The results showed that 1) male PCPs were less likely to
adopt RF-HT than female PCPs (adjusted odds ratio [aOR] = 0.524, 95%CI = 0.290–0.948,
p = 0.033); 2) PCPs who worked in public sector were less likely to adopt RF-HT (aOR = 0.524,
95%CI = 0.292–0.940, p = 0.030); 3) PCPs whose training status in Hong Kong Academy of
Medicine (HKAM) were “Nil to completed basic training” (aOR = 0.479, 95%CI = 0.269–
0.853, p = 0.012) or “Higher trainee” (aOR = 0.302, 95%CI = 0.093–0.979, p = 0.046) were less
likely to have high RF-HT adoption, and 4) being academic fellow was a marginal significant
factor for RF-HT adoption (aOR = 1.748, 95%CI = 0.982–3.111, p = 0.058).
Table 1. Participant characteristics (n = 383).
Characteristics Number (%)
Age
30 36 (9.4)
31–40 88 (23.0)
41–50 87 (22.7)
51–60 88 (23.0)
>60 83 (21.7)
Gender
Male 246 (64.2)
Female 135 (35.2)
Practice experience since graduation frommedical school
<5 years 24 (6.3)
5–10 years 34 (8.9)
11–15 years 60 (15.7)
16–20 years 74 (19.3)
21–25 years 45 (11.7)
26–30 years 49 (12.8)
>30 years 96 (25.1)
Clinical practice
In public sector 182 (47.5)
In private sector 201 (52.5)
Solo 111 (29.0)
With partners 64 (16.7)
Others 92 (24.0)
Academic tutor 91 (23.8)
General Out-Patient Clinic 190 (49.6)
Family Medicine Integrated Clinic 93 (24.3)
Training status in Hong Kong Academy of Medicine (HKAM)
Nil 131 (34.2)
Basic Trainee 34 (8.9)
Completed basic training 35 (9.1)
Higher trainee 20 (5.2)
Completed higher training 19 (5.0)
Academy fellow 137 (35.8)
Having Specialty 175 (46.5)
Family Medicine 110 (28.7)
Pediatrics 23 (6.0)
Others 42 (11.0)
https://doi.org/10.1371/journal.pone.0205529.t001
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Furthermore, suggestions to further improve the adoption level of reference framework
among doctors were shown in Table 5, i.e. simplification of RF-HT (91.9%), provision of
pocket versions (86.4%) and RF-HT promotion in patients in a patient-centered manner
(81.9%).
Discussion
Summary
In the current study, the adoption level, as well as associated factors of PCPs with respect to
the reference framework for hypertension in Hong Kong was evaluated and reported. The
average score of adoption was high as 3.43/4.00, and 47.5% of PCPs highly adopted this frame-
work in their daily consultations. Gender, practice sector and training status were indicated as
significant associated factors to adoption level by multivariate logistic regression. The most
suggested modifications of the guidelines are simplification of RF-HT, provision of pocket ver-
sion and promoting in patients.
Strengths and limitations
Since there was no standardized local hypertension guideline or recommendation applicable
for the whole healthcare system in Hong Kong before 2010, RF-HT developed by Department
of Health, HKSAR is the first-ever standardized recommendations of hypertension care cover-
ing the whole system. Hence, it is desirable and necessary to evaluate the adoption level and
Table 2. Adoption level of recommendations in daily consultations of physicians (n = 383).
Recommendations Proportion of participants who highly
adopt the recommendation (%)
a. Measure blood pressure (BP) for hypertensive patients at every visit. 366 (95.6)
b. Measure blood pressure (BP) for high risk individuals at every visit 345 (90.1)
c. Measure blood pressure (BP) for individuals aged >18 years old, every 2
years
168 (43.9)
d. Set target BP < 130/80 mm Hg for hypertensive patients with diabetes
or chronic kidney disease.
204 (53.3)
e. Consider BP <140/80 mm Hg as the optimal treatment goal for simple
hypertensive patients.
343 (89.6)
f. Advice overweight/obese individuals to achieve healthy body weight. 365 (95.3)
g. Advise hypertensive patients to maintain optimal body weight and
adopt healthy eating habit.
367 (95.8)
h. Advise hypertensive patients to increase regular level of physical
activity.
366 (95.6)
i. Advise hypertensive patients to stop smoking, and start smoking
cessation counseling.
365 (95.3)
j. Advise hypertensive patients to restrict salt intake. 360 (94.0)
k. Start drug treatment within a month If BP between 160-179/100-109
mmHg
365 (95.3)
l. Prescribe ACEI, calcium channel blocker or thiazide-type diuretic to
treat hypertension.
357 (93.2)
m. Increase dosage or adding third drug from different class if BP goal was
not reached after primary treatment in hypertensive patients.
364 (95.0)
n. Annual screening for Urine for protein/ albumin in hypertensive
patients
316 (82.5)
o. Annual screening for Fasting blood glucose in hypertensive patients 355 (92.7)
https://doi.org/10.1371/journal.pone.0205529.t002
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associated factors regarding this first-ever standardized RF-HT. This evaluation shall deliver
important messages for further improvement and updates.
There are several strengths apparently observed in this study. Firstly, we recruited partici-
pant PCPs who were working in both the public and private sectors, allowing us to collect a
wide variety of opinions. Secondly, the targeting results were obtained by a validated survey,
which helped to clarify the situation of RF-HT adopted by PCPs in Hong Kong. Thirdly, find-
ings of this study showed that the RF-HT was highly adopted among the PCPs in Hong Kong
with associated factors identified. These strengths may provide stakeholders and policy makers
with a clear blueprint for further improvement of the RF-HT and also the future development
of other local guideline and reference.
In the meantime, the study had some limitations. We contacted and sent invitations to pri-
mary care practitioners in Hong Kong based on contact information from several databases.
However, participants who were eligible may not be reached, and this may reduce the gener-
alizability of the findings. The low response rate (9.9%) may affect its representativeness.
Moreover, response bias may exist in self-report, and recall bias may be inevitable when asking
PCPs on the details in their practices. Therefore, the high adoption rate of the RF-HT could be
coincidental. Nevertheless, the findings that recommendations in the RF-HT were integrated
into their regular hypertensive management implied high acceptance of the reference frame-
work among PCPs and the capability of translating recommendations into practice.
Table 3. Participant characteristics according to the level of adoption of the reference framework.
Characteristics High adoption [n = 182] (%) Low adoption [n = 201] (%) p
Age
30 11 (6.0) 25 (12.4) 0.038
31–60 124 (68.1) 139 (69.2)
>60 47 (25.8) 37 (18.4)
Gender
Male 108 (59.3) 138 (56.1) 0.078
Practice experience since graduation frommedical school
<10 years 18 (9.9) 40 (19.9) 0.007
>10 years 164 (90.1) 161 (80.1)
Clinical practice
Public sector 78 (42.9) 104 (57.1) 0.082
Private sector 104 (57.1) 97 (48.3)
Academic fellow
Yes 53 (29.1) 38 (18.9) 0.010
Having specialty
Yes 94 (51.6) 81 (40.3) 0.012
Specialty in family medicine
Yes 54 (48.2) 58 (51.8) 0.861
Training status in HKAM
Nil to completed basic training 85 (48.2) 115 (57.5) 0.008
Higher trainee 5 (2.8) 15 (7.5)
Completed higher training to academic fellow 86 (48.9) 70 (35.0)
The Chi-square test was employed for the analysis of categorical data.
P-value <0.05 is considered as at significant level.
https://doi.org/10.1371/journal.pone.0205529.t003
Hypertension reference framework in HK
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Fig 1. Treatment algorithm for pharmacological management of hypertension.
https://doi.org/10.1371/journal.pone.0205529.g001
Hypertension reference framework in HK
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Fig 2. The extend of agreement with the treatment algorithm for hypertensive patients.
https://doi.org/10.1371/journal.pone.0205529.g002
Table 4. Factors associated with adoption of the reference framework by multivariate logistic regression analysis.
Adjusted Odds Ratio 95% CI p
Lower Upper
Gender
Female Reference
Male 0.524 0.290 0.948 0.033
Clinical practice
Private sector Reference
Public sector 0.524 0.292 0.940 0.030
Training status in HKAM
Completed higher training to Academic fellow Reference
Higher trainee 0.302 0.093 0.979 0.046
Nil to Completed basic training 0.479 0.269 0.853 0.012
Academic tutor
No Reference
Yes 1.748 0.982 3.111 0.058
P-value <0.05 is considered as at significant level.
https://doi.org/10.1371/journal.pone.0205529.t004
Hypertension reference framework in HK
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Comparison with existing literature
In contrast to the moderate or low adherence of hypertension guidelines reported in other
countries, this study showed a high adoption of the RF-HT in Hong Kong. Significant differ-
ences in reference framework adoption were observed associated with the demographic char-
acteristics. The proportion of participants who reported older age, longer practice experience
after graduation, higher level of training status, having medical specialty and working as aca-
demic tutor, were more likely to adopt the reference framework. In existing literatures, age
and practice experience are two frequently-discussed factors of PCP adherence to guidelines.
Our findings are consistent with that reported by the literature [34], i.e. older PCPs who have
longer practice experience may stick to the guidelines, and are less affected by external
circumstances.
Moreover, most of the recommendations given on BP measurement, lifestyle modification
and drug treatment were highly-adopted by PCPs except three recommendations with rela-
tively low adoption. These implied that (a) lifestyle modification should have been widely rec-
ommended to patients in clinical practice, which showed a much higher adoption by PCPs in
Hong Kong than other regions [10, 16, 17]; (b) there is no consensus on “Set target BP< 130/
80 mmHg”, which may be also a clinical issue in Hong Kong. This may indicate that some phy-
sicians may lack incentives in achieving BP target [10]. (c) The moderate adoption of annual
uric acid screening for hypertensive patients may be due to the fact that thiazide-type diuretic
was not considered as a first line drug for hypertension by 64.7% of PCPs.
Furthermore, potential associated factors indicated by multivariate logistic regression con-
sisted of both demographic factors and independent factors identified from four themes of
potential factors of RF-HT adoption in this study. The results suggest that a) PCPs’ postgradu-
ate education may play an important role in guideline adherence as reported in the literature;
b) PCPs with higher qualifications may have more accessibility to RF-HT. One potential expla-
nation is that this may be related to their teaching responsibility during their vocational train-
ing because they may have teaching duty during their academic work.
Several effective solutions were reported in the literatures to improve the adherence rate of
reference framework or guideline for chronic disease management, these include establish-
ment of a professional team formed by physicians, pharmacists, nurses and related staff [18,
35], electronic documentation and computer-aided decision making system [16, 18, 21, 36,
37], reminder delivery to PCPs [38] and promotion of continuing medical education (CME)
Table 5. Adoption level of improvements on enhancing the use of reference framework for hypertension care in
your clinical practice (n = 383).
Suggestions on improvement Proportion of participants who highly adopt
the suggestions (%)
a. Simplifying the framework into flow sheets or slogans. 351 (91.9)
b. Providing pocket versions (i.e. mobile phone apps). 330 (86.4)
c. Providing multi-lingual patient version. 301 (79.0)
d. Including a referral system, with contact information of other
medical care providers.
289 (75.9)
e. Scheduling the implementation process of primary care
physicians.
282 (74.4)
f. Promoting framework to patients. 313 (81.9)
g. Easing financial burden on patients through medical fee
waiving mechanism.
280 (74.1)
h. Monitoring the compliance of the reference framework. 295 (77.4)
https://doi.org/10.1371/journal.pone.0205529.t005
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in PCPs [6, 12, 18, 20, 21, 39]. In this study, simplifying RF-HTs is strongly supported by PCPs
in order to make it easier to understand and make it more accessible. Specifically, provision of
pocket version is one of suggested vehicles to increase RF-HT adoption, e.g. mobile apps. At
the same time, most of participants expected that RF-HT should be promoted to patients,
which they believed could improve patients’ knowledge of hypertension and motivate them to
adopt healthier lifestyles.
Implications for research and/or practice
There was high adoption to the recommendations in RF-HT among PCPs in Hong Kong in
this cross-sectional survey. Factors associated with adoption to reference framework were
identified. Future work can make use of these findings to improve and reinforce the imple-
mentation of this framework. Moreover, making the RF more accessible and portable may
help to further improve the adoption rate in this population.
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